Trial intelligence / Profile preview

Anakinra for palmoplantar pustulosis

2015-003600-23Phase 4Completed

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
Jan 2016
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Palmoplantar Pustular Psoriasis (PPPP) and pustular psoriasis comparing Anakinra with Placebo (2 arms). Primary endpoints: Change in disease activity over 8 weeks, Fresh pustule count and 1 more. Started Jan 2016; status: completed.

02

Drugs

anakinra
03

Conditions

Palmoplantar Pustular Psoriasis (PPPP)pustular psoriasis

Beyond the preview

Go deeper on 2015-003600-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003600-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call